Back to search
FDAFDA · Food and drugs·Recall number D-0749-2026

SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01

Published August 19, 2026 · Recall initiated: July 29, 2026

Summary

FDA records drug Class II recall D-0749-2026, published August 19, 2026 and initiated July 29, 2026. Recalling firm: Apollo Care, LLC; Status: Ongoing; Reported quantity: 37,546 vials.; Lot: Lot: C-017115, Exp. 11/25/2026; AC-017163, Exp. 12/31/2026; AC-017169, AC-017170, AC-017171, Exp. 12/31/2026; AC-017230, AC-017231, Exp. 5/5/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apollo Care, LLC
Distributor
Nationwide within the U.S
Lot
Lot: C-017115, Exp. 11/25/2026; AC-017163, Exp. 12/31/2026; AC-017169, AC-017170, AC-017171, Exp. 12/31/2026; AC-017230, AC-017231, Exp. 5/5/2027.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01 recalled?

Yes. FDA published recall D-0749-2026 on August 19, 2026. Reported hazard: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail